Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Research Frontiers (REFR) Capital Expenditures (2016 - 2025)

Research Frontiers' Capital Expenditures history spans 10 years, with the latest figure at -$16.0 for Q4 2025.

  • For Q4 2025, Capital Expenditures changed N/A year-over-year to -$16.0; the TTM value through Dec 2025 reached $786.0, changed N/A, while the annual FY2025 figure was $726.0, 55.27% down from the prior year.
  • Capital Expenditures for Q4 2025 was -$16.0 at Research Frontiers, down from $110.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $702.0 in Q1 2023 and bottomed at -$39.0 in Q3 2023.
  • The 5-year median for Capital Expenditures is $149.0 (2022), against an average of $278.94.
  • The largest annual shift saw Capital Expenditures tumbled 126.17% in 2023 before it skyrocketed 1607.69% in 2024.
  • A 5-year view of Capital Expenditures shows it stood at $111.0 in 2021, then plummeted by 50.45% to $55.0 in 2022, then surged by 432.73% to $293.0 in 2023, then surged by 100.68% to $588.0 in 2024, then plummeted by 102.72% to -$16.0 in 2025.
  • Per Business Quant, the three most recent readings for REFR's Capital Expenditures are -$16.0 (Q4 2025), $110.0 (Q1 2025), and $588.0 (Q3 2024).